Nutrition and biotechnology in heart disease and cancer / edited by John B. Longenecker, David Kritchevsky, and Marc K. Drezner.
- 其他作者：
- 出版： Milton Keynes, UK : Lightning Source UK Ltd. [2012?]
- 叢書名： Advances in experimental medicine and biology ; ;v.369
- 主題： Heart Diseases--etiology. , Heart Diseases--physiopathology. , Biotechnology. , Diet. , Neoplasms--etiology , Neoplasms--physiopathology. , Nutritional Physiological Phenomena
- ISBN： 9781461358046 (pbk.) :: US$101.78 、 1461358043 (pbk.)
- 一般註：Includes bibliographical references and index. "Proceedings of a conference on Nutrition and biotechnology in heart disease and cancer, held December 5-7, 1993, in Research Triangle Park, North Carolina"--Title page verso Reprint. Originally published: New York: Springer Science+Business Media, c1995.
-
讀者標籤：
- 系統號： 005210579 | 機讀編目格式
館藏資訊
There is a unique nutritional commonality developing in research relating to coronary heart disease and cancer. The primary aim of this conference was to provide a forum for the leading researchers, clinicians, educators and administrators in these two fields to present a program on heart disease and cancer which included a) the major historical milestones, b) the present areas of greatest interest in research and therapy, c) the latest nutritional, molecular, and biotechnological advances, and d) a perspective on the most promising areas for future research and therapy. Scientists have long contended that research marches on the feet of methodology. Thus there are numerous examples of research fields opening secondary to methodological advances. Some examples are: 1) thin layer and gas-liquid chromatography which, along with high pressure liquid chromatography have broadened the line of advances in lipid research and 2) peR and the resultant impact on molecular biological approaches to several fields of science. The organizers of this conference thought the time was propitious for bringing together knowledge on newer aspects of molecular biological research with current advances in the two major areas of degenerative disease--coronary heart disease and cancer. Our knowledge of these "killer diseases" has expanded greatly in the past few years and the advance has been catalyzed by use of an array of molecular biological techniques. Thanks to these, medical thinking in these areas is changing from considerations of treatment to strategies for prevention.